Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2010
09/01/2010CN101817871A Edwardsiella tarda quorum sensing blocking factor, construction and application thereof
09/01/2010CN101245098B Antimicrobial antiphlogistic antagonism polypeptide simulating MD2
09/01/2010CN101054409B Amphiphilic short peptide and use thereof
08/2010
08/31/2010US7786258 Methods for inhibiting immune complex formation in a subject
08/31/2010US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics
08/31/2010US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody
08/31/2010US7786085 Method for treating a patient undergoing chemotherapy
08/31/2010US7786079 Substituted nonadepsipeptides
08/31/2010US7786078 cyclic polypeptides; inhibitor of chemokine receptors; biodrugs as antiinflammatory agent, anticarcinogenic agent; preventing HIV infections; drug target
08/31/2010US7785588 Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors
08/31/2010US7785577 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb
08/31/2010US7785566 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II
08/31/2010CA2332817C Il-6 antagonist peptides
08/26/2010WO2010096693A2 Methods and materials for generating t cells
08/26/2010WO2010096681A2 Modifications of cupredoxin derived peptides and methods of use thereof
08/26/2010WO2010096604A2 Uses of cancer-targeting peptides in cancer diagnosis
08/26/2010WO2010096603A2 Cancer-targeting peptides and uses thereof in cancer therapy
08/26/2010WO2010096385A2 Methods and compositions for the treatment of autoimmune disease
08/26/2010WO2010095953A1 Process for purifying lipopeptides
08/26/2010WO2010095753A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
08/26/2010WO2010095365A1 Evaluation peptide for use in quantification of protein using mass spectrometer, artificial standard protein, and method for quantifying protein
08/26/2010US20100216973 Methods for the specific preparation of lysobactin fragments
08/26/2010US20100216969 Immobilisation of polypeptides by irradiation
08/26/2010US20100216724 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/26/2010US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
08/26/2010US20100216721 Inhibition of HIV-1 Infection by Potent Metallocene Conjugated Peptide Through Conformational Entrapment of Envelope GP120
08/26/2010US20100216701 Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes
08/26/2010US20100216699 Semi-synthetic glycopeptides having antibacterial activity
08/26/2010US20100216663 Novel proteins with targeted binding
08/26/2010US20100216253 Organic Material-Immobiling Structure and Method for Production of the Same, and Peptide and DNA Therefor
08/26/2010US20100216182 Cyanine-Based Probe\Tag-Peptide Pair Fluorescence Protein Imaging and Fluorescence Protein Imaging Methods
08/26/2010US20100216180 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
08/26/2010US20100216173 Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215675 Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
08/26/2010US20100215649 Antibodies for norovirus
08/26/2010US20100215636 Peptides derived from plasminogen activator inhibitor-1 and uses thereof
08/26/2010CA2748932A1 Process for purifying lipopeptides
08/25/2010EP2219668A1 Binding epitopes for g250 antibody
08/25/2010CN1795386B Diagnosis of autism
08/25/2010CN101815724A aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
08/25/2010CN101812449A Method for preparing small cyclopeptide
08/25/2010CN101812126A Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof
08/25/2010CN101812120A South Africa II type foot-and-mouth disease epitope polypeptide and screening method thereof
08/25/2010CN101812119A Polypeptide combined with immune antibody and application thereof
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101812040A Corossolone derivative, preparation method and application thereof
08/25/2010CN101054410B Antigen epitope III of neutrality B cell of chicken IBDV VP2 protein and application thereof
08/24/2010US7781488 convergent assembly of a plurality of pairs of oligopeptides; stable C-terminal disulfide-protected carboxythioester group that can be deprotected to spontaneously generate a free C-terminal thioester; allows a single precursor to participate in a succession of chemical ligation reactions
08/24/2010US7780968 Clostridial toxin derivatives and methods for treating pain
08/24/2010CA2551182C Novel kappa receptor selective opioid peptides
08/24/2010CA2201396C Multifunctional molecular complexes for gene transfer to cells
08/24/2010CA2181924C Diagnosis and treatment of infections due to streptococci and enterococci
08/19/2010WO2010091893A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
08/19/2010WO2010054326A3 C-terminal fragments of glucagon-like peptide-1 (glp-1)
08/19/2010WO2010046900A3 Rgd-containing peptidomimetics and uses thereof
08/19/2010US20100210818 Nucleic acids encoding the human alex1 protein
08/19/2010US20100210817 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
08/19/2010US20100210816 NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia
08/19/2010US20100210566 Azapeptides as cd36 binding compounds
08/19/2010US20100210564 Drug or food containing a peptide
08/19/2010US20100210563 Metastasis-specific peptides and their diagnostic and therapeutic applications
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210558 Minigastrin as a therapeutic agent
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100210544 Peptides and pharmaceucal compositions for treating connective tissue
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210516 Growth Factor Binding Molecules
08/19/2010US20100209998 Cell-permeabilising peptides and polypeptides for microbial cells
08/19/2010US20100209945 Method for preparing antibody monolayers which have controlled orientation using peptide hybrid
08/19/2010US20100209939 Bnp(1-32) epitope and antibodies directed against said epitope
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209390 Cyclosporin analogues
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010CA2751436A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217623A2 T-cell receptor peptides specific for part of cd20 , uses thereof, and methods of preparing cytotoxic t-cells
08/18/2010EP2217615A2 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides
08/18/2010EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
08/18/2010EP1390521B1 Glycopeptide antibiotics
08/18/2010CN101809148A Novel immunotherapy against neuronal and brain tumors
08/18/2010CN101809029A Peptide capable of extending half-life of peptide of interest in plasma
08/18/2010CN101809028A Novel lipid peptide and hydrogel
08/18/2010CN101808660A Vaccine peptide combinations against cat allergy
08/18/2010CN101805394A Anti-opioid peptide active fragment
08/18/2010CN101805393A REPLIKIN peptides and uses thereof
08/18/2010CN101805392A Anti-inflammatory antibacterial polypeptide capable of blocking combination of LPS and MD2
08/17/2010US7777011 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
08/17/2010US7776828 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production
08/17/2010US7776562 Reversible MHC multimer staining for functional purification of antigen-specific T cells
08/17/2010US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics
08/17/2010CA2506580C Assay kit and antibody for human low molecular weight cd14
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/12/2010WO2010090744A1 Methods and compositions for treating neuropathies
08/12/2010WO2010089554A1 Peptides for vaccine
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 423